Action Seeking Judgment of Compliance with FRAND Obligations Survives Only Insofar as it Relates to U.S. Patent Rights

Mar 11, 2020

Reading Time : 2 min

Under the applicable regional circuit law, before exercising jurisdiction in a declaratory judgment action, a district court must decide (1) whether an “actual controversy” exists between the parties; (2) whether it has authority to grant declaratory relief; and (3) whether to exercise its broad discretion to decide or dismiss a declaratory judgment action. Moreover, when assessing a Rule 12(b)(1) motion, “the district court is to accept as true the allegations and facts set forth in the complaint.”

Optis’ complaint alleged that it engaged in “good faith efforts to license [its] essential patents to Apple on FRAND terms” but that “Apple ha[d] not reciprocated [those] efforts.” Optis accordingly requested declaratory judgment that: (1) Optis’ efforts complied with the Intellectual Property Rights Policy of the European Telecommunications Standards Institute; (2) the efforts “were consistent with competition law requirements”; (3) Optis had “no US liability based on [its] conduct”; and (4) Apple “may no longer raise a FRAND defense in the US.”

In its motion to dismiss, Apple argued that “the [c]ourt did not have or should decline jurisdiction over [Optis’] claim as it relates to foreign patents.” Optis further argued that, as such, there would be no “actual controversy” set forth in the complaint because the alleged licensing efforts all included foreign patents and thus “any determination of whether a hypothetical offer for a U.S.-only license complied with FRAND obligations would be an [improper] advisory opinion.”

Judge Gilstrap agreed with Apple’s first argument and concluded that “foreign obligations under foreign laws related to foreign patents are best left to the courts of those foreign countries.” But he disagreed that there was no “actual controversy” simply because the alleged licensing offers all included foreign patents. According to the court, a patentee need not “make individual license offers for standard essential patents in each country in order to be deemed to have complied with its FRAND and other obligations in that country.” And “while a global license would involve foreign patents subject to foreign FRAND obligations, [it] would also involve U.S. patents subject to U.S. FRAND and anti-competition obligations.” As Judge Gilstrap explained, the U.S. components of the license could conceivably be “extricated” from the foreign components, and Optis should not be denied the opportunity to make such a showing.

To support its motion, Apple relied heavily on a prior case in which Judge Gilstrap dismissed both foreign and U.S. claims when a party sought judgment of FRAND compliance based on a “worldwide” licensing offer. See Optis Wireless Technology, LLC v. Huawei Technologies Co., No. 2:17-CV-00123-JRG-RSP, 2018 WL 3375192 (E.D. Tex. July 11, 2018). Judge Gilstrap determined that Huawei was distinguishable because of its “very different procedural posture.” In Huawei, dismissal occurred “after a bench trial in which [the plaintiffs] failed to present any evidence that they had offered a license to U.S.-only patents.” The plaintiffs’ expert in Huawei “testified that he ha[d] offered no opinions as to whether there was FRAND compliance by [the plaintiff] with respect to only U.S. patents.” According to Judge Gilstrap, “such a failure of proof in the Huawei case should not preclude [Optis] from attempting to offer such proof in this case.”

Practice Tip: Parties involved in foreign litigation related to the licensing of SEPs under FRAND terms must recognize the effects of foreign actions and foreign licensing activities on U.S. litigation. Jurisdiction and eventual judgment in the U.S. hinges on allegations and evidence that is tied to U.S. patent rights.

Optis Wireless Technology, LLC et al v. Apple Inc., 2:19-cv-00066-JRG (E.D. Tex. Mar. 2, 2020) (Gilstrap, J.)

Share This Insight

Previous Entries

IP Newsflash

November 14, 2025

The Ninth Circuit recently reversed a district court’s decision to strike a plaintiff’s trade secret claims under the Defend Trade Secrets Act (DTSA) at the discovery stage. In doing so, the Ninth Circuit made clear that under the DTSA, whether a party defined their trade secret with sufficient particularity is a question of fact that generally does not lend itself to resolution in the absence of at least some discovery. This ruling contrasts with the California Uniform Trade Secrets Act (CUTSA), which requires a party to define their trade secrets with reasonable particularity before commencing discovery.

...

Read More

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

IP Newsflash

October 31, 2025

The District Court for the Northern District of California recently granted a defendant’s motion to bifurcate, ordering that issues related to PGR estoppel should be decided in a bench trial, while the remaining issues in the case should proceed to a jury trial.

...

Read More

IP Newsflash

October 31, 2025

The Northern District of Iowa recently held that a defendant’s motion for partial summary judgment of invalidity was barred after the PTAB issued final written decisions, regardless of when the motion was filed. The defendant filed its motion before the final written decisions were issued, but the court rejected the defendant’s argument that the timing of the motion insulated it from estoppel.

...

Read More

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.